The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data

被引：0
|
作者：
Lerman, T. [1 ]
Yacoby, I [1 ]
Fishman, B. [2 ]
Goldman, A. [2 ]
Talmor-Barkan, Y. [1 ]
Itelman, E. [1 ]
Orvin, K. [1 ]
Eisen, A. [1 ]
Kornowski, R. [1 ]
Levi, A. [1 ]
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Sheba Med Ctr, Ramat Gan, Israel
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data
    Lerman, T.
    Yacoby, I.
    Fishman, B.
    Goldman, A.
    Talmor-Barkan, Y.
    Itelman, E.
    Orvin, K.
    Eisen, A.
    Kornowski, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data
    Lerman, Tsahi T.
    Greenberg, Noam
    Fishman, Boris
    Goldman, Adam
    Talmor-Barkan, Yeela
    Bauer, Menachem
    Goldberg, Idan
    Goldberg, Elad
    Kornowski, Ran
    Krause, Ilan
    Levi, Amos
    Cohen, Eytan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 397
  • [3] The real-world safety profile of SGLT2 inhibitors among adults 75 years or older: a retrospective, pharmacovigilance study
    Goldman, A.
    Fishman, B.
    Raschi, E.
    Cukierman-Yaffe, T.
    Dankner, R.
    Ben-Zvi, I.
    Maor, E.
    EUROPEAN HEART JOURNAL, 2022, 43 : 973 - 973
  • [4] The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study
    Adam Goldman
    Boris Fishman
    Gilad Twig
    Emanuel Raschi
    Tali Cukierman-Yaffe
    Yonatan moshkovits
    Alon Pomerantz
    Ilan Ben-Zvi
    Rachel Dankner
    Elad Maor
    Cardiovascular Diabetology, 22
  • [5] The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study
    Goldman, Adam
    Fishman, Boris
    Twig, Gilad
    Raschi, Emanuel
    Cukierman-Yaffe, Tali
    Moshkovits, Yonatan
    Pomerantz, Alon
    Ben-Zvi, Ilan
    Dankner, Rachel
    Maor, Elad
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [6] A real-world pharmacovigilance study of sacubitril\valsartan in older people: data mining of the FDA adverse event reporting system
    Kuai, Zheng
    Li, Quan
    Zhang, Xiaoyi
    Tang, Guowen
    Ye, Yangli
    Hu, Yu
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [7] Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data
    Tu, Jiakuan
    Zhang, Chaoxiang
    Qiu, Yichun
    Zhang, Hao
    Zheng, Jiaxin
    Xie, Shuihua
    He, Jianhua
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [8] Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system
    Zhang, Zhiyuan
    Yao, Yifan
    Zhu, Li
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] Pharmacovigilance in a real-world data setting - a comparative study
    Mouresan, Elena Flavia
    Forsberg, Lars
    Glaser, Anna
    Hillert, Jan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 659 - 660
  • [10] A REAL-WORLD PHARMACOVIGILANCE STUDY OF SACUBITRIL\VALSARTAN IN OLDER PEOPLE
    Kuai, Zheng
    Hu, Yu
    INNOVATION IN AGING, 2024, 8 : 132 - 132
12345